Auxiliadora Falcon-Romero

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study.

Effect of Delayed Initiation of Mepolizumab on EXACTO Scale Scores, Clinical Remission SEPAR-REMAS Criteria, and Functional Outcomes in Uncontrolled Severe Asthma: A Real-World Study.

Journal: Medical sciences (Basel, Switzerland)

Published: May 31, 2026

Prevalence of Asthma and Associated Comorbidities in the Spanish Population: A Cross-sectional Survey.

Prevalence of Asthma and Associated Comorbidities in the Spanish Population: A Cross-sectional Survey.

Journal: Open respiratory archives

Published: December 12, 2025

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

Journal: Journal of asthma and allergy

Published: October 05, 2025

Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study.

Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study.

Journal: Pulmonary pharmacology & therapeutics

Published: August 19, 2025

Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations

Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations

Journal: Open respiratory archives

Published: July 16, 2025

FEV1 decline and clinical predictors in asthma after 10 Years of follow-up: BMI as a modifiable risk factor.

FEV1 decline and clinical predictors in asthma after 10 Years of follow-up: BMI as a modifiable risk factor.

Journal: Respiratory medicine

Published: April 20, 2025

Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.

Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.

Journal: Archivos de bronconeumologia

Published: January 18, 2025

Evaluation of Different Doses in Inhaled Therapy: A Comprehensive Analysis.

Evaluation of Different Doses in Inhaled Therapy: A Comprehensive Analysis.

Journal: Pharmaceutics

Published: August 07, 2023

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma.

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma.

Journal: Journal of asthma and allergy

Published: January 16, 2022

Effectiveness of Text Message Reminders on Adherence to Inhaled Therapy in Patients With Asthma: Prospective Multicenter Randomized Clinical Trial.

Effectiveness of Text Message Reminders on Adherence to Inhaled Therapy in Patients With Asthma: Prospective Multicenter Randomized Clinical Trial.

Journal: JMIR formative research

Published: September 22, 2018

Algorithm for the management of asthma in pregnant women: a protocol to optimize processes in healthcare.

Algorithm for the management of asthma in pregnant women: a protocol to optimize processes in healthcare.

Journal: Expert review of respiratory medicine

Published: October 11, 2017

Is the bronchodilator test an useful tool to measure asthma control?

Is the bronchodilator test an useful tool to measure asthma control?

Journal: Respiratory medicine

Published: August 29, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026